Organization · Venture Capital
Forge Life Science Partners
Forge Life Science Partners is a Massachusetts-based venture capital firm specializing in the life sciences sector, focusing on innovative therapeutics and technologies across various stages of company development.
Overview
What Forge Life Science Partners does
What Forge Life Science Partners is
Forge Life Science Partners is a Massachusetts-based venture capital firm specializing in the life sciences sector, focusing on innovative therapeutics and technologies across various stages of company development.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find Forge Life Science Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Forge Life Science Partners as a funder
Investment thesis
Forge Life Science Partners focuses on investing in innovative therapeutics and technologies within the life sciences sector, targeting early-stage to growth-stage companies.
Focus narrative
The firm invests primarily in biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health. Forge Life Science Partners emphasizes innovative therapeutics and technologies, focusing on companies at various stages of development, from early-stage to growth-stage.
Value beyond capital
Forge Life Science Partners provides significant value to its portfolio companies through its experienced team, extensive network in the biotech industry, and strong institutional backing from B-FLEXION. This enables them to support companies not only with capital but also with strategic guidance and connections in the healthcare sector.
Terms and economics
- Typical check
- $1,000,000–$120,000,000
- Sweet spot
- $10,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Growth Equity
- Sectors
- Biotech · Healthcare · Medical Devices · Digital Health · Pharma Tech
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
- Recorded notable exits
- Escient Pharmaceuticals and IDRx
Portfolio context
Forge Life Science Partners has made a total of 6 investments, primarily in Series A rounds for US-based startups. Notable portfolio companies include Escient Pharmaceuticals, where they led a $120M Series C round, and SAB Biotherapeutics. The firm has also achieved two successful exits via acquisition, including Escient Pharmaceuticals and IDRx.
Common questions
What to know about Forge Life Science Partners
Upseed classifies Forge Life Science Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.